When it came time to write about the CLOSURE-AF trial of percutaneous left atrial appendage closure (LAAC) vs best medical therapy in patients with atrial fibrillation (AF) at high risk for both stroke and bleeding, I expected to have to explain how the noninferiority design obscured the…